Open AccessBioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma
Author(s) -
Zhenyu Xie,
Yu Lun,
Xin Li,
Yuzhen He,
Song Wu,
Shiyue Wang,
Jianjian Sun,
Yuchen He,
Jian Zhang
Publication year - 2020
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.103645
Subject(s) - cancer research , biomarker , thyroid carcinoma , immune system , methylation , thyroid cancer , papillary thyroid cancer , cancer , biology , metastasis , dna methylation , oncology , medicine , gene expression , gene , thyroid , immunology , genetics
AHNAK2 has been recently reported as a biomarker in many cancers. However, a systematic investigation of AHNAK2 in papillary thyroid carcinoma (PTC) has not been conducted.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom